Target
Tyrosine-protein kinase JAK2
Ligand
BDBM50399018
Substrate
n/a
Meas. Tech.
ChEMBL_874070 (CHEMBL2186603)
IC50
242±n/a nM
Citation
 Hanan, EJvan Abbema, ABarrett, KBlair, WSBlaney, JChang, CEigenbrot, CFlynn, SGibbons, PHurley, CAKenny, JRKulagowski, JLee, LMagnuson, SRMorris, CMurray, JPastor, RMRawson, TSiu, MUltsch, MZhou, ASampath, DLyssikatos, JP Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitors. J Med Chem 55:10090-107 (2012) [PubMed]  Article 
Target
Name:
Tyrosine-protein kinase JAK2
Synonyms:
JAK-2 | JAK2 | JAK2_HUMAN | Janus kinase 2 | Janus kinase 2 (JAK2) | Janus kinase 2 (a protein tyrosine kinase)
Type:
Protein
Mol. Mass.:
130684.68
Organism:
Homo sapiens (Human)
Description:
O60674
Residue:
1132
Sequence:
MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
  
Inhibitor
Name:
BDBM50399018
Synonyms:
CHEMBL2177122
Type:
Small organic molecule
Emp. Form.:
C17H12Cl2N6O
Mol. Mass.:
387.223
SMILES:
Cn1cc(NC(=O)c2cnn3cccnc23)c(n1)-c1c(Cl)cccc1Cl |(4.01,-28.58,;5.47,-28.11,;5.95,-26.65,;7.5,-26.65,;8.41,-25.41,;7.78,-24,;6.25,-23.83,;8.69,-22.76,;8.22,-21.29,;9.46,-20.38,;10.71,-21.29,;12.22,-20.97,;13.26,-22.13,;12.78,-23.6,;11.26,-23.91,;10.23,-22.76,;7.96,-28.12,;6.71,-29.02,;9.43,-28.6,;10.57,-27.58,;10.25,-26.08,;12.03,-28.06,;12.35,-29.57,;11.19,-30.6,;9.73,-30.11,;8.58,-31.14,)|
Structure:
Search PDB for entries with ligand similarity: